Cary Claiborne

Mr. Cary J.
Claiborne is an Independent External Director at Neurosense Therapeutics Ltd. He is on the Board of Directors at Virginia Biotechnology Association and Neurosense Therapeutics Ltd. Mr. Claiborne was previously employed as an Independent Director by LadRx Corp., a President, Chief Executive Officer & Director by Adial Pharmaceuticals, Inc., a Chief Executive Officer by Prosperity Capital Management LLC, a Chief Financial Officer by Reckitt Benckiser Pharmaceuticals, Inc., a Chief Financial Officer & Director by Indivior PLC, a Chief Financial Officer by Sucampo Pharmaceuticals LLC, a Head-Investor Relations by New Generation Biofuels Holdings, Inc., a Chief Financial Officer & Secretary by Osiris Therapeutics, Inc., a Vice President-Financial Planning & Analysis by Constellation Energy Group, Inc., a Vice President-Financial Planning & Analysis by The Home Depot, Inc., a Vice President-Financial Planning & Analysis by Manufacturers Components, Inc., a Vice President-Financial Planning & Analysis by MCI, Inc., a Chief Financial Officer & Senior Vice President by GE Capital Business Processes Management Services Ltd., a Director-Operations Analysis by General Electric Capital Corp., and a Chief Financial Officer by New Generation Biofuels, Inc. He also served on the board at The Medicalert Foundation.
He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Villanova University.